Allergan, Inc. (NYSE: AGN) announced the FDA has approved LATISSE 0.03% as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE